drink kool-aid
remain uw fear materi ebitda
downsid play quarter big miss
much wors expect guidanc
exacerb sizeabl write-down account adjust
post sec subpoena dividend cut
remain underweight continu recent string materi quarterli
ebitda downsid ebitda miss vs consensu
ebitda guidanc far consensu also announc
larg impair charg associ kraft oscar mayer brand
small magnitud cog base disconcert
account adjust sec subpoena relat procur save
dividend cut clearli result issu impair
charge/account change/dividend cut disappoint expect
stock significantli see littl reason investor buy
weak given signific issu lack visibl one key
question clear deck set stage return
ebitda growth see kitchen sink guidanc
ebitda miss vs consensu estim includ roughli
increment reinvest amount
put behind busi end
result sustain improv trend consensu
ebitda declin sinc ep report also
continu believ unsustain high price gap vs privat label
product us see initi report assum coverag uw
unsustain diet recent januari report price pressur
heighten ebitda risk greater detail expand significantli
recent year like requir greater price adjust point
ebitda guidanc consensu guid
adj ebitda consensu y-o-i
midpoint driver consensu guid includ much higher
expect cost inflat net save estim neg fx/brand
divestitur lower start base lower core growth
food unit state america
unless otherwis note metric base modelwar
base consensu methodolog
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
net reinvestment/high variabl compens also expect
ep headwind non-oper item estim impli ep
declin nearli y-o-i consid headwind lower y-
o-i ebitda expect posit organ sale growth price
expect declin y-o-i exclud impact key pass-through commod
well top-line headwind divestitur currenc
first quarter expect high teen declin adj ebitda organ
sale declin neg holiday time trade time
notabl item earn releas sever notabl
develop took impair charg associ kraft
natur chees oscar mayer cold cut us refriger canada
retail busi magnitud write signal materi chang
futur expect although indic tie weak recent
margin perform also receiv subpoena sec
octob associ procur area agreement
vendor record increas result correct previous
report result sec investig conclud
compani discov materi weak far yet
file delay possibl magnitud chang
materi concern account issu
seem uncov issu reduc annual dividend
divestitur announc focus divestitur go forward
addit announc divestitur order improv growth trajectori
strengthen balanc sheet medium term goal time net
number adj ep
consensu estim signific ebitda downsid gross margin
weak gross profit consensu organ sale growth
line consensu report revenu came
consensu slightli oner fx gross margin declin bp yoy
bp consensu expect lead gross profit miss
gross profit downsid augment slightli higher sg sale
bp yoy bp consensu drive oper profit miss
miss ex account charg profit line item
includ cent benefit lower interest expens cent benefit
lower incom tax net cent benefit vs model
reduc estim price remain underweight net post ep
reduc alreadi consensu ep estim
respect reduc profit outlook revis
ebitda amplifi higher tax rate/high net interest
expense/high depreci reduc pt
dcf-deriv sales/ebitda/fcf compound-annual-growth-rate wacc tgr
post impli estim ev/ebitda
multipl price-to-earnings multipl yield reduct ntm
dcf valu attribut reduc ebitda outlook greater
capit intens higher capital-expenditure work capit remain uw
detail
co khc neg risk/reward ebitda downsid valuat risk
neg risk/reward ebitda downsid valuat risk
deriv base case scenario
growth acceler margin upsid bp top-line upsid us market
share gain int upsid drive organ sale compound-annual-growth-rate
bps/yr margin expans top-line leverag resumpt product
compound-annual-growth-rate post wacc tgr exit multipl strateg
premium consolid halo return
stabil follow expect ebitda declin
model stabil start ebitda compound-annual-growth-rate growth
outsid north america mostli off-set continu weak
wacc tgr exit multipl
top-line deceler margin pressur continu bp top-line downsid
linger us market share struggl drive organ sale
compound-annual-growth-rate margin declin bps/yr price pressur fix cost de-lever
higher reinvest drive ebitda compound-annual-growth-rate dcf input
revenue/ebitda compound-annual-growth-rate post wacc tgr exit
growth rebound back lsd
rang lower price deep dive
us busi sale
highlight leverag low/no growth
end market weak competit posit
momentum backdrop
compound-annual-growth-rate toward bottom peer
margin expans remain
cautiou abil simultan
expand margin deliv inflect
revenu confirm much weaker
expect result
metric alreadi best-in-class
wide margin ii advertis
food peer declin
greater rate iii competit
market share intensifi believ price net
key commod pnoc may come
pressur alreadi evid us scanner data
despit pronounc pullback
stock ebitda
view valuat compel consid
long-term ebitda compound-annual-growth-rate
well peer average coupl
risk achiev price
trend price environ increment
strateg potenti sector rotat
cash equival
s-t debt interest payabl
accumul comprehens incom loss
total liabil stockhold equiti
bridg gaap net incom
adjust reconcil net incom
depreci amort
defer compens stock compens
chang oper asset liabil effect
account payabl accru expens
net cash flow oper activ
flow invest activ
sale busi
purchas busi
net cash flow invest activ
flow financ activ
repurchas common share
issuanc common share
net cash flow financ activ
effect fx chang cash cash equival
cash equival begin year
net chang cash cash equival
cash equival end year
